Global Presence Helios Global Group operates across multiple key markets including the UK and the US, providing an extensive geographic reach that presents opportunities for tailored healthcare communications and technology solutions across diverse healthcare landscapes.

Strategic Acquisitions The recent acquisition of Cogentia indicates an active growth strategy and openness to integrating specialized agencies, which could facilitate cross-selling of advanced communication and evidence-based solutions to expand their service offerings.

Private Equity Backing Now owned by Telemos Capital, a private equity firm, Helios Global Group may have increased investment capacity, creating prospects for scalable technology upgrades, innovative services, and expanded operational capacity to attract larger pharmaceutical clients.

Market Focus With a focus on medical affairs, market access, and commercialization, there are opportunities to offer digital platforms, data analytics, and technology solutions that enhance client engagement, compliance, and market penetration efforts.

Financial Range Generating revenue between 10 and 25 million dollars and employing a sizable team, Helios demonstrates stability and growth potential, making it a promising target for partner solutions that support efficiency, scalability, and competitive advantage in healthcare communications.